posted on 2016-09-12, 00:00authored byAlberuni M. Zamah, Maria E. Hassis, Matthew E. Albertolle, Katherine E. Williams
Background: Follicular fluid is a unique biological fluid in which the critical events of oocyte and follicular maturation and somatic cell-germ cell communication occur. Because of the intimate proximity of follicular fluid to the maturing oocyte, this fluid provides a unique window into the processes occurring during follicular maturation.
A thorough identification of the specific components within follicular fluid may provide a better understanding of
intrafollicular signaling, as well as reveal potential biomarkers of oocyte health for women undergoing assisted
reproductive treatment. In this study, we used high and low pH HPLC peptide separations followed by mass
spectrometry to perform a comprehensive proteomic analysis of human follicular fluid from healthy ovum donors.
Next, using samples from a second set of patients, an isobaric mass tagging strategy for quantitative analysis was
used to identify proteins with altered abundances after hCG treatment.
Results: A total of 742 follicular fluid proteins were identified in healthy ovum donors, including 413 that have not
been previously reported. The proteins belong to diverse functional groups including insulin growth factor and insulin
growth factor binding protein families, growth factor and related proteins, receptor signaling, defense/immunity,
anti-apoptotic proteins, matrix metalloprotease related proteins, and complement activity. In a quantitative analysis, follicular fluid samples from age-matched women undergoing in vitro fertilization oocyte retrieval were compared
and 17 follicular fluid proteins were found at significantly altered levels (p < 0.05) between pre-hCG and post-hCG
samples. These proteins belong to a variety of functional processes, including protease inhibition, inflammation, and
cell adhesion.
Conclusions: This database of FF proteins significantly extends the known protein components present during the
peri-ovulatory period and provides a useful basis for future studies comparing follicular fluid proteomes in various
fertility, disease, and environmental exposure conditions. We identified 17 differentially expressed proteins after hCG
treatment and together these data showed the feasibility for defining biomarkers that illuminate how the ovarian follicle microenvironment is altered in various infertility-related conditions.
Funding
This work was supported by a grant to AMZ from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development
sponsored Women’s Reproductive Health Research Career Development
Program [K12 HD001262-12]. Additional funding for this project was also
Zamah et al. Clinical Proteomics (2015) 12:5 Page 9 of 12
supported by a grant from the American Society of Reproductive Medicine
to AMZ. The UCSF Sandler-Moore Mass Spectrometry Core Facility.